Skip to main content
FinSpry Logo
FinSpry
TMDX logo
TMDX
(NASDAQ)
TransMedics Group, Inc.
$94.77-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

TransMedics Group (TMDX) Stock Price & Financial Analysis

TransMedics Group Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$90.45 - $95.18
52-Week High$156.00
52-Week Low$60.11
Open$91.11
Volume626.88K
Average Volume (3M)922.50K
Market Cap3.43B
Shares Outstanding36.19M
P/E Ratio (TTM)18.60
Forward P/E10.18
Price to Sales (P/S)5.03
Price to Book (P/B)6.47
EV/EBITDA25.76
Revenue (TTM)635.89M
Net Income (TTM)171.92M
Free Cash Flow (TTM)151.36M
EPS (TTM)$4.34
Profit Margin27.04%
Operating Margin14.85%
Return on Equity (ROE)34.80%
Debt to Equity1.75
50-Day MA$75.85
200-Day MA$107.09
52-Week Change-30.73%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About TransMedics Group

What is the current stock price for TMDX?

As of the latest trading session, TMDX stock trades at $94.77. The 52-week range is $60.11–$156.00, with a day range of $90.44–$95.18.

What is the P/E ratio for TMDX?

TransMedics Group's trailing P/E ratio is 18.6, meaning investors pay $18.6 for every $1 of annual earnings. The forward P/E is 10.2, reflecting analyst expectations for future earnings. TransMedics Group operates in the Healthcare sector.

Does TMDX pay dividends?

TransMedics Group does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for TMDX?

Based on 7 analysts, the consensus for TMDX is Buy.

What is the market cap of TMDX?

TransMedics Group's market capitalization is $3.43B, classifying it as a mid-cap company. TransMedics Group operates in the Healthcare sector within the Medical Devices industry.